← Back to All Filings
Royalty Pharma Director Bonnie L. Bassler Receives Shares in Lieu of Retainer
Royalty Pharma plc
$RPRX4CIK: 0001802768
Subscribe to track RPRX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📊 Royalty Pharma plc ($RPRX) Insider: Bonnie L. Bassler (Director) Type: Acquisition (Award / Retainer) | Shares: 642 @ $58.41 (~$37.5K) Shares Owned After: 79,823 Significance: Low (Quarterly director retainer paid in shares)
Comprehensive Analysis
Transaction Analysis
- Reporting Person: Bonnie L. Bassler, Director at Royalty Pharma plc ($RPRX).
- Transaction Summary: On September 30, 2026, Dr. Bassler acquired 642 Class A Ordinary Shares at a price of $58.4055 per share, representing a total value of approximately $37,500.
- Nature of Transaction: As noted in the filing footnotes, these shares were issued under the issuer's 2020 Independent Director Equity Incentive Plan in lieu of a standard quarterly cash retainer payment of $37,500.
- Holdings Post-Transaction: Following this acquisition, Dr. Bassler directly holds 79,823 Class A Ordinary Shares.
- Market Significance: Low. This transaction reflects routine board compensation rather than an open-market purchase or discretionary trading activity.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.